Results 131 to 140 of about 697,317 (200)
ABSTRACT Oxaliplatin is a platinum‐based anticancer agent widely used for gastrointestinal malignancies; however, it is known to cause dose‐dependent peripheral neuropathy (OIPN), a characteristic adverse effect. OIPN results in a reduced quality of life and often necessitates dose reduction or discontinuation of oxaliplatin; however, effective ...
Yusuke Koura +11 more
wiley +1 more source
Abstract Cerebrotendinous xanthomatosis (CTX) is a treatable genetic disorder associated with deficiency of the sterol 27‐hydroxylase enzyme (CYP27A1), important in bile acid synthesis. CTX may present in the newborn period as hepatic jaundice/cholestasis, that can resolve or can progress to fatal liver disease.
Andrea E. DeBarber +3 more
wiley +1 more source
Nail Surgery in Children: Specific Challenges and Practical Considerations
ABSTRACT Nail surgery in children represents a specific field within dermatologic surgery. Although the procedures themselves are largely similar to those performed in adults, the indications, technical constraints, and perioperative management differ substantially. Pediatric nail disorders are often clinically recognizable, which frequently limits the
F. Lamoline, B. Richert
wiley +1 more source
Introduction: Serum vitamin D levels has been hypothesized to influence the progress of diabetes and its various complications. The role of Vitamin D in diabetic peripheral neuropathy have been debated.
Tammineni Roja +5 more
doaj
Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population
OBJECTIVE: To assess the prevalence of peripheral neuropathy (PN) and its correlation with cryoglobulinemia (CG) in an unselected, untreated referral hepatitis C virus (HCV) population.
AND HCV PERIPHERAL NERVE STUDY GROUP BASSI F +8 more
core
ABSTRACT The study aimed to investigate the efficacy of ultrasound‐guided intercostal nerve block (ICNB) with liposomal bupivacaine (LB) comparing ropivacaine‐dexamethasone (RD) for treating postherpetic neuralgia (PHN) in adult patients. A total of 108 patients were randomized 1:1 to receive ICNB with LB or ICNB with RD.
Jin Li, Xiang‐Yu Fang
wiley +1 more source
Pregabalin Efficacy in Treatment of Chronic Neurogenic Cough
The use of neuromodulators for chronic cough has increased; however, the choice of medication, dosing regimen, and duration are still unclear. This longitudinal study of 95 adults taking pregabalin, 75 mg twice daily, for CNC demonstrated 78% improvement or resolution of cough, 17% unchanged, 1% worse cough, with a mean of 6 weeks of therapy, and only ...
Jacqui Allen +3 more
wiley +1 more source
Laryngeal Cryotherapy for Neurogenic Cough: Safety, Feasibility, and Prospective Outcomes
A prospective clinical trial investigated the safety and clinical outcomes of office‐based selective laryngeal cryotherapy for patients with refractory chronic cough. Patient were followed for 6 months posttreatment and had durable improvement in cough severity index and urge‐to‐cough scores and no serious long term adverse effects.
Shumon I. Dhar +6 more
wiley +1 more source
Diagnostic Delay of Unilateral Facial Paralysis Caused by Occult Malignancy: A Scoping Review
This scoping review of 27 studies (66 patients) characterizes unilateral facial paralysis caused by occult malignancy, a rare entity marked by a mean diagnostic delay of 21 months and initially negative imaging in 89% of cases. Progressive paralysis, lack of recovery, trigeminal or additional cranial nerve involvement, and a history of regional skin ...
Kai C. Kokesh +4 more
wiley +1 more source

